Q-omics provides the consensus-scored LBHD2 profile across patient tissues and cancer cell-line models. Additionally, LBHD2 RNA expression shows 6,025 significant protein co-abundance associations, with the highest sampling consensus in CCRCC.

Every result is evaluated using two consensus scores. Sampling consensus measures how consistently a finding is reproduced within a cancer lineage across different conditions. Lineage consensus measures how broadly the result is shared across cancer types, distinguishing pan-cancer signals from lineage-specific patterns.

Premium analyses for LBHD2 — synthetic lethality, tumor antigen, and pembrolizumab response.

View premium →

Cross-omics associations

This table shows molecular features associated with LBHD2 in patient tissues and cancer cell lines. In patient samples, LBHD2 shows the broadest associations at the RNA and protein expression levels, with CCRCC recurring as the lineage with the largest associated feature set. In cancer cell lines, LBHD2 RNA and mutation anchors are most strongly linked to RNA-expression features, especially in BONE, while CRISPR and shRNA rows add functional-dependency signals in OVARY.

Associated data type	Strength (# associated data)	Lineage of highest associated data
▼RNA
Protein (mass-spec)	6,025	CCRCC (2501)	view →
Function (mass-spec)	572	CCRCC (299)	view →
▼Protein (mass-spec)
Protein (mass-spec)	322	LSCC (229)	view →
Function (mass-spec)	254	BRCA (203)	view →

Associated data type	Strength (# associated data)	Lineage of highest associated data
▼RNA
RNA	1,487	BONE (507)	view →
Function (RNA)	747	OVARY (276)	view →